These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17501689)

  • 1. New therapy for the prevention and prophylactic treatment of acute radiation syndrome.
    Zenk JL
    Expert Opin Investig Drugs; 2007 Jun; 16(6):767-70. PubMed ID: 17501689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice.
    Singh VK; Fatanmi OO; Wise SY; Carpenter A; Nakamura-Peek S; Serebrenik AA; Kaytor MD
    Int J Radiat Biol; 2022; 98(5):958-967. PubMed ID: 34554032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2020 May; 29(5):429-441. PubMed ID: 32450051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against ionizing radiation by antioxidant nutrients and phytochemicals.
    Weiss JF; Landauer MR
    Toxicology; 2003 Jul; 189(1-2):1-20. PubMed ID: 12821279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters.
    Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M
    Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use.
    Singh VK; Hanlon BK; Santiago PT; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):885-906. PubMed ID: 28657400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants reduce consequences of radiation exposure.
    Okunieff P; Swarts S; Keng P; Sun W; Wang W; Kim J; Yang S; Zhang H; Liu C; Williams JP; Huser AK; Zhang L
    Adv Exp Med Biol; 2008; 614():165-78. PubMed ID: 18290327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.
    Singh VK; Romaine PL; Seed TM
    Health Phys; 2015 Jun; 108(6):607-30. PubMed ID: 25905522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDP: A Deinococcus Mn2+-Decapeptide Complex Protects Mice from Ionizing Radiation.
    Gupta P; Gayen M; Smith JT; Gaidamakova EK; Matrosova VY; Grichenko O; Knollmann-Ritschel B; Daly MJ; Kiang JG; Maheshwari RK
    PLoS One; 2016; 11(8):e0160575. PubMed ID: 27500529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status.
    Singh VK; Garcia M; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):870-884. PubMed ID: 28657406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation countermeasure agents: an update.
    Dumont F; Le Roux A; Bischoff P
    Expert Opin Ther Pat; 2010 Jan; 20(1):73-101. PubMed ID: 20021286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioprotective agents to prevent cellular damage due to ionizing radiation.
    Smith TA; Kirkpatrick DR; Smith S; Smith TK; Pearson T; Kailasam A; Herrmann KZ; Schubert J; Agrawal DK
    J Transl Med; 2017 Nov; 15(1):232. PubMed ID: 29121966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.
    Mishra KN; Moftah BA; Alsbeih GA
    Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute.
    Singh VK; Ducey EJ; Brown DS; Whitnall MH
    Int J Radiat Biol; 2012 Apr; 88(4):296-310. PubMed ID: 22191567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizing radiation-induced altered microRNA expression as biomarkers for assessing acute radiation injury.
    Singh VK; Pollard HB
    Expert Rev Mol Diagn; 2017 Oct; 17(10):871-874. PubMed ID: 28792262
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation countermeasure agents: an update (2011-2014).
    Singh VK; Newman VL; Romaine PL; Wise SY; Seed TM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1229-55. PubMed ID: 25315070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive or potential therapeutic value of nutraceuticals against ionizing radiation-induced oxidative stress in exposed subjects and frequent fliers.
    Giardi MT; Touloupakis E; Bertolotto D; Mascetti G
    Int J Mol Sci; 2013 Aug; 14(8):17168-92. PubMed ID: 23965979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation.
    Zivkovic Radojevic M; Milosavljevic N; Miladinovic TB; Janković S; Folic M
    Int J Radiat Biol; 2023; 99(4):594-603. PubMed ID: 35930681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental validation of prevention of the development of stochastic effects of low doses of ionizing radiation based on the analysis of human lymphocytes' chromosome aberrations.
    Diomina EA; Chekhun VF
    Exp Oncol; 2013 Mar; 35(1):65-8. PubMed ID: 23528319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.